Back to CYTK
Royalty Pharma Sub-Manager, LLC → CYTK
Royalty Pharma Sub-Manager, LLC CYTK Position History
Cytokinetics, Incorporated • Healthcare
Quarters held
6
Latest value
$83.5M
Q2 2026
Peak value
$83.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $62.3M |
| Q4 2025 | $62.3M |
| Q1 2026 | $64.6M |
| Q1 2026 | $64.6M |
| Q2 2026 | $83.5M |
| Q2 2026 | $83.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $83.5M | 980.4K | — | — |
| Q2 2026 | $83.5M | 980.4K | — | — |
| Q1 2026 | $64.6M | 980.4K | — | — |
| Q1 2026 | $64.6M | 980.4K | — | — |
| Q4 2025 | $62.3M | 980.4K | — | — |
| Q4 2025 | $62.3M | 980.4K | — | — |
Other funds holding CYTK
$704.4M
$601.9M
$555.8M
$553.2M
$553.2M
$492M